FDA-Cleared Tool Helps Clinicians Diagnose Autism in Children

Neurora, cleared by the FDA this month, measures more than 100 vocal, facial, and gaze biometrics from standard behavioral assessments to help clinicians diagnose autism in children 18 months to 12 years old. A study found it distinguished children with and without autism in nearly 78% of cases, a boost for families facing long waits for evaluation.